What is PBLS's current stock price?

PBLS (Parabilis Medicines, Inc.) is currently trading at $39.11 with a market cap of $4.56B.

What sector is Parabilis Medicines, Inc. in?

Parabilis Medicines, Inc. (PBLS) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

PBLS Parabilis Medicines, Inc.

NASDAQHealthcare

$39.11-0.46%ClosedMarket Cap: $4.56B

As of 2026-08-28

Why PBLS matters now

Parabilis Medicines, Inc. (PBLS) is a US stock in Healthcare. The latest InvestLog snapshot shows $39.11 with -0.46% on the session and $4.56B in market capitalization.

The latest indexable market news headline is "Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D." from GlobeNewsWire.

Latest News

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D.GlobeNewsWire · 2026-08-25

Parabilis Medicines: A Rare-Tumor Validation Ladder For An Undruggable PlatformSeeking Alpha · 2026-08-14

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewsWire · 2026-08-13

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More247 Wallst · 2026-07-06

This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · 2026-07-06

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.